160 Health and Shuangjia Medical Sign Strategic Cooperation to Co-Build an Integrated Solution for Tiered Diagnosis and Public Health Services

On March 15, the online healthcare service platform Jiuyi 160 and Shenzhen Shuangjia Medical Technology Co., Ltd. (hereinafter referred to as “Shuangjia Medical”) signed a strategic cooperation agreement at Jiuyi 160’s Shenzhen headquarters. The two parties will engage in multifaceted collaboration across product development, channel expansion, and capital investment. Chen Ying, Chairman of Shuangjia Medical, and Liu Kanglin, Senior Vice President of Jiuyi 160 and CEO of Shenzhen 160 Network Technology Co., Ltd., along with other executives from both companies, attended the signing ceremony.

Some analysts have stated that the integration of product projects between Health 160 and Shuangjia Medical is the top priority of their collaboration. Among these, the jointly launched comprehensive solution for tiered diagnosis and treatment and public health services will better promote the implementation of tiered diagnosis and treatment, create a health ecosystem more aligned with China’s national conditions, and improve and optimize a public health service system better suited to China’s specific context.

Liu Kanglin, Senior Vice President of 91160 (Jiuyi 160), stated that tiered diagnosis and treatment play a pivotal role in the company’s strategic development framework. In June 2016, 91160 pioneered the launch of China’s first patient-centric internet-based tiered diagnosis and treatment platform strategy. At its core, this strategy focuses on patients, fully mobilizing the participation of both patients and physicians, reconstructing healthcare pathways, and enhancing medical service efficiency. This initiative was regarded by the industry as a groundbreaking innovative practice. In future collaborations, the two parties will fully leverage 91160’s tiered diagnosis and treatment platform alongside Shuangjia Medical’s “Internet + Public Health” service offerings to create a distinctive, integrated solution for tiered diagnosis and treatment and public health services.

Chen Ying, Chairman of Shuangjia Medical, also stated that through years of development, Jianyi 160 has established products and services with distinct competitive advantages. Shuangjia Medical possesses the strength and confidence to provide technical support for this collaboration, achieving a win-win outcome. This partnership aims to create a health ecosystem more closely aligned with real-world medical practices by leveraging a model of “Internet + Healthcare + Cross-industry Collaboration.”

In addition to co-developing integrated solutions for tiered diagnosis and treatment as well as public health services, the appointment registration platform of Jiuyi 160 will also integrate with hardware devices such as Shuangjia Medical Health Kiosks and all-in-one self-service terminals, along with their corresponding project solutions. This collaboration aims to establish and open new appointment channels for community residents, thereby extending the service depth of Shuangjia Medical. Once mature, the initiative can be further expanded into areas such as remote consultation and diagnosis.

At the level of channel resources, both parties will share their channel resources, leverage their respective strengths, collaborate and refer clients to each other, and jointly develop the market. Meanwhile, starting from April 2017, both parties will jointly expand customer resources in medical channels across various provinces and cities in China and match cooperative projects by organizing regional cooperation salon tours and other initiatives.

Furthermore, building on their strong prior collaboration, the two parties will also engage in beneficial trials and explorations in areas such as capital operations and financing for initial public offerings (IPOs) starting this year.